February 27, 2015 6:52 AM ET


Company Overview of Q-Med Scandinavia, Inc.

Company Overview

Q-Med Scandinavia, Inc. provides products for the treatment of vesicoureteral reflux (VUR). Its products include DEFLUX, which is a gel that is used in endoscopic injections to treat VUR. The company is based in Princeton, Virginia. Q-Med Scandinavia, Inc. operates as a subsidiary of Q-Med AB. As of June 4, 2009, Q-Med Scandinavia, Inc. operates as a subsidiary of Oceana Therapeutics, Inc.

103 Carnegie Center

Suite 301

Princeton, NJ 08540

United States





Key Executives for Q-Med Scandinavia, Inc.

Q-Med Scandinavia, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
MyoKardia, Inc. United States
Indiana Protein Technologies Inc United States
Pinnacle Pharmaceuticals, Inc. United States
Targesome, Inc. United States
Inologic Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Q-Med Scandinavia, Inc., please visit www.deflux.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.